TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
EV/CE(x) | 2.89 | 3.36 | 0.80 |
What is the latest EV/CE ratio of TRIDENT LIFELINE ?
Year | EV/CE |
---|---|
Mar2024 | 2.89 |
Mar2023 | 3.36 |
Mar2022 | 0.80 |
How is EV/CE of TRIDENT LIFELINE Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.89 | -13.99 | |
Mar2023 | 3.36 | 320.00 | |
Mar2022 | 0.8 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹322.0 Cr | 3% | -3.8% | 46% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 3.7% | 8.5% | 49.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 3.6% | 1.8% | 52.1% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 3% | 1.9% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 2.7% | 15.5% | 23.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -1.6% | 1% | 43.9% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 3% |
-3.8% |
46% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses